Marshak Richard — SEC Form 4 filings
SEC reporting owner CIK 1982638. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-25 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 10,597 shares, $49,832 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 6,597 shares @ $5.18 ($34,172) in TriSalus Life Sciences, Inc., filed 2025-05-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TriSalus Life Sciences, Inc. (TLSI) | Chief Commercial Officer | 10 | — | 5 legs · 10,597 sh · $49,832 | 12 |
Form 4 filings — Marshak Richard
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 561 @ $3.87 | EDGAR |
| 2026-05-19 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Sale (S): 543 @ $2.67 | EDGAR |
| 2026-03-20 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Sale (S): 1,449 @ $4.13 · Sale (S): 1,589 @ $4.09 · Sale (S): 419 @ $4.12 | EDGAR |
| 2025-11-25 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 60,000 @ $0 · Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 21,428 @ $5.18 · Sale (S): 6,597 @ $5.18 | EDGAR |
| 2025-02-19 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 7,644 @ $0 | EDGAR |
| 2025-01-29 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 12,500 @ $0 · Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-11-15 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 6,875 @ $0 · Grant/award (A): 41,250 (derivative) @ $0 | EDGAR |
| 2024-02-14 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 14,752 @ $0 · Grant/award (A): 63,750 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | TriSalus Life Sciences, Inc. (TLSI) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1982638 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →